Silicon Valley Light the Night Walk, Fundraiser for Leukemia and Lymphoma Patients, Set for Oct. 22

Silicon Valley Light the Night Walk, Fundraiser for Leukemia and Lymphoma Patients, Set for Oct. 22

The Silicon Valley 2016 Light the Night Walk, a fundraising campaign by the Leukemia & Lymphoma Society (LLS) to raise money to support blood cancer patients, will take place Oct. 22 at Avaya Stadium in San Jose, California.

Light the Night walks are the LLS’s flagship fundraiser, bringing together families and communities to honor blood cancer survivors and those lost to the disease. The events also highlight the importance of finding new treatments through research, and of providing access to therapies for patients.

The Silicon Valley event starts with food and festivities at 5 p.m., and the walk itself will take place at 7 p.m. Festivities will involve children-friendly activities, a musical show, and an area for team photos.

The event will also include a dedicated ‘Reflections of Life’ tent featuring stories of Honored Heroes – local leukemia and lymphoma patients or survivors recognized for their bravery and courage, and a survivors’ lounge. This year’s honoree is Liam, diagnosed at 1½ years old with acute myeloid leukemia (AML).

During the walk, participants carry lightened lanterns to demonstrate how their lives have been affected by cancer. Supporters will carry red lanterns, survivors white lanterns, and gold lanterns will be given to those walking in memory of a loved one lost to blood cancer.

September was  Blood Cancer Awareness Month, and LLS notes that, although a lot of progress has been made in past years, more work is still necessary to save lives. In the United States, over 1.2 million people are living with or in remission from a blood cancer. Leukemia alone is responsible for more deaths among children and young people than any other cancer, the group reported.

“Join us as we Light The Night with hope, and bring help and support to those affected by blood cancer,” Courtney Karnes, LLS executive director, said in a news release.

LLS aims to find better treatments, and eventually a cure, for leukemia, lymphoma, Hodgkin’s disease, and myeloma patients, as well as to improve the quality of life of patients and their families.

Leave a Comment

Your email address will not be published. Required fields are marked *